MCID: INT071
MIFTS: 42

Intestinal Perforation malady

Categories: Gastrointestinal diseases

Aliases & Classifications for Intestinal Perforation

Aliases & Descriptions for Intestinal Perforation:

Name: Intestinal Perforation 12 42 14 69
Perforation of Intestine 12

Classifications:



External Ids:

Disease Ontology 12 DOID:2074
ICD9CM 35 569.83
MeSH 42 D007416
NCIt 47 C39611
SNOMED-CT 64 56905009
ICD10 33 K63.1
UMLS 69 C0021845

Summaries for Intestinal Perforation

MalaCards based summary : Intestinal Perforation, also known as perforation of intestine, is related to perinatal intestinal perforation and peritonitis. An important gene associated with Intestinal Perforation is PTS (6-Pyruvoyltetrahydropterin Synthase), and among its related pathways/superpathways are Shigellosis and Arginine and proline metabolism. The drugs Ertapenem and Aspirin have been mentioned in the context of this disorder. Affiliated tissues include small intestine, bone and lung, and related phenotype is digestive/alimentary.

Related Diseases for Intestinal Perforation

Diseases related to Intestinal Perforation via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 100)
id Related Disease Score Top Affiliating Genes
1 perinatal intestinal perforation 12.1
2 peritonitis 10.3
3 7q11.23 duplication syndrome 10.1 NOS1 PTS
4 pseudo-gaucher disease 10.1 NOS1 PTS
5 typhoid fever 10.0
6 small cell carcinoma 9.9 NKX2-1 PTS
7 tuberculosis 9.9
8 purpura 9.9
9 lymphoma 9.8
10 miliary tuberculosis 9.8
11 crohn's disease 9.8
12 inguinal hernia 9.8
13 polyarteritis nodosa 9.8
14 cytomegalovirus infection 9.8
15 temporal arteritis 9.7
16 arthritis 9.7
17 patent ductus arteriosus 9.7
18 rheumatoid arthritis 9.7
19 vaginitis 9.6
20 pleomorphic carcinoma 9.6
21 umbilical hernia 9.6
22 ehlers-danlos syndrome 9.6
23 churg-strauss syndrome 9.6
24 candidiasis 9.6
25 intussusception 9.6
26 fibromatosis 9.6
27 vasculitis 9.6
28 systemic lupus erythematosus 9.5
29 paroxysmal nocturnal hemoglobinuria 9.5
30 heart disease 9.5
31 constipation 9.5
32 adenosquamous carcinoma 9.5
33 lupus erythematosus 9.5
34 renal tubular dysgenesis 9.5
35 abdominal tuberculosis 9.5
36 osteogenesis imperfecta 9.5
37 pancreatitis 9.5
38 fasciolopsiasis 9.5
39 renal cell carcinoma 9.5
40 chorioamnionitis 9.5
41 hemolytic-uremic syndrome 9.5
42 gastroenteritis 9.5
43 pneumonia 9.5
44 meningitis 9.5
45 myelodysplastic syndrome 9.5
46 hypertrophic pyloric stenosis 9.5
47 angiodysplasia 9.5
48 pulmonary embolism 9.5
49 alpha chain disease 9.5
50 pyloric stenosis 9.5

Comorbidity relations with Intestinal Perforation via Phenotypic Disease Network (PDN): (show all 15)


Active Peptic Ulcer Disease Acute Cystitis
Acute Kidney Failure Cecal Benign Neoplasm
Colorectal Cancer Deficiency Anemia
Familial Atrial Fibrillation Heart Disease
Intestinal Obstruction Mesenteric Artery Ischemia
Paralytic Ileus Peritonitis
Protein-Energy Malnutrition Rectosigmoid Junction Neoplasm
Respiratory Failure

Graphical network of the top 20 diseases related to Intestinal Perforation:



Diseases related to Intestinal Perforation

Symptoms & Phenotypes for Intestinal Perforation

MGI Mouse Phenotypes related to Intestinal Perforation:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 digestive/alimentary MP:0005381 9.02 NFKB1 NKX2-1 NOD2 NOS1 PTS

Drugs & Therapeutics for Intestinal Perforation

Drugs for Intestinal Perforation (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 225)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ertapenem Approved, Investigational Phase 4,Phase 2 153832-46-3 150610
2
Aspirin Approved, Vet_approved Phase 4,Phase 3 50-78-2 2244
3
Metronidazole Approved Phase 4,Phase 3,Phase 2 443-48-1 4173
4
Acetaminophen Approved Phase 4,Phase 2 103-90-2 1983
5
Ampicillin Approved, Vet_approved Phase 4 69-53-4 6249
6
Ceftazidime Approved Phase 4 78439-06-2 5481173
7
Clindamycin Approved, Vet_approved Phase 4 18323-44-9 29029
8
Bupivacaine Approved, Investigational Phase 4 2180-92-9, 38396-39-3 2474
9
Levobupivacaine Approved Phase 4 27262-47-1 92253
10
Ceftriaxone Approved Phase 4 73384-59-5 5479530 5361919
11
Minocycline Approved, Investigational Phase 4 10118-90-8 5281021
12
Tigecycline Approved Phase 4 220620-09-7 5282044
13 Anesthetics Phase 4,Phase 3
14 Fibrin Tissue Adhesive Phase 4
15 Hemostatics Phase 4,Phase 3,Phase 2
16 Liver Extracts Phase 4
17 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2
18 Antibiotics, Antitubercular Phase 4,Phase 3,Phase 2
19 Anti-Infective Agents Phase 4,Phase 3,Phase 2
20 Antitubercular Agents Phase 4,Phase 3,Phase 2
21 Analgesics Phase 4,Phase 3,Phase 2
22 Analgesics, Non-Narcotic Phase 4,Phase 3,Phase 2
23 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2
24 Anti-Inflammatory Agents, Non-Steroidal Phase 4,Phase 3,Phase 2
25 Antipyretics Phase 4,Phase 3,Phase 2
26 Antirheumatic Agents Phase 4,Phase 3,Phase 2
27 Cyclooxygenase Inhibitors Phase 4,Phase 3,Phase 2
28 Fibrinolytic Agents Phase 4,Phase 3
29 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2
30 Platelet Aggregation Inhibitors Phase 4,Phase 3,Phase 2
31 Antiparasitic Agents Phase 4,Phase 3,Phase 2
32 Antiprotozoal Agents Phase 4,Phase 3,Phase 2
33 Clindamycin palmitate Phase 4
34 Clindamycin phosphate Phase 4
35 Gentamicins Phase 4
36 Anesthetics, Local Phase 4
37 Central Nervous System Depressants Phase 4
38
Lansoprazole Approved, Investigational Phase 3 103577-45-3 3883
39
Fluconazole Approved Phase 3 86386-73-4 3365
40
Miconazole Approved, Investigational, Vet_approved Phase 3 22916-47-8 4189
41 Simethicone Approved Phase 3
42
Amoxicillin Approved, Vet_approved Phase 3,Phase 2 26787-78-0 33613 2171
43
Cefuroxime Approved Phase 3,Phase 2 55268-75-2 5361202 5479529
44
Celecoxib Approved, Investigational Phase 3 169590-42-5 2662
45
Naproxen Approved, Vet_approved Phase 3,Phase 2 22204-53-1 1302 156391
46
Oxaliplatin Approved, Investigational Phase 3,Phase 2 61825-94-3 5310940 9887054 6857599, 9887054 43805
47
Epinephrine Approved, Vet_approved Phase 3 51-43-4 5816
48
Vancomycin Approved Phase 2, Phase 3 1404-90-6 441141 14969
49
Fluorouracil Approved Phase 3 51-21-8 3385
50
Capecitabine Approved, Investigational Phase 3 154361-50-9 60953

Interventional clinical trials:

(show top 50) (show all 158)
id Name Status NCT ID Phase
1 Radiofrequency Ablation Versus Hepatic Resection for the Treatment of Hepatocellular Carcinomas Smaller Than 2 cm Unknown status NCT01351194 Phase 4
2 Antibiotics Versus Surgery in Acute Appendicitis Unknown status NCT01421901 Phase 4
3 Evaluation of Use of Plastic Bags to Prevent Neonatal Hypothermia-Part IV Completed NCT01604447 Phase 4
4 Evaluate the Use of Plastic Bags in Preventing and Treating Hypothermia in Neonates Completed NCT01403623 Phase 4
5 The Effects of Aspirin and Acetaminophen on the Stomach in Healthy Volunteers Completed NCT00594867 Phase 4
6 Impact of Oral Application of Gastrografin on the Meconium Evacuation in Very Low Birth Weight Infants Completed NCT01515696 Phase 4
7 Fast-track Surgery for Perforated Peptic Ulcers Completed NCT01620671 Phase 4
8 Prospective Randomized Evaluation of Antibiotic Regimen Following Appendectomy for Perforated Appendicitis Completed NCT00195923 Phase 4
9 Pain Reduction After Cholecystectomy Completed NCT01199406 Phase 4
10 Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection Completed NCT00195351 Phase 4
11 Evaluation of Use of Plastic Bags to Prevent Neonatal Hypothermia-Part II Recruiting NCT01604421 Phase 4
12 Evaluation of Use of Plastic Bags to Prevent Neonatal Hypothermia-Part I Recruiting NCT01604317 Phase 4
13 Evaluation of Use of Plastic Bags to Prevent Neonatal Hypothermia-Part III Recruiting NCT01604434 Phase 4
14 Once Daily Metronidazole for Perforated Appendicitis Not yet recruiting NCT02561117 Phase 4
15 Clinical Study-evaluate Performance&Safety "Aer-O-Scope" in Colon of Low Risk Patients Unknown status NCT00867724 Phase 2, Phase 3
16 Comparison of Infant Pain Responses Between Two Different Methods of Urine Collection Unknown status NCT00298584 Phase 3
17 The Effect of Gum Chewing on Postoperative Ileus Unknown status NCT00879294 Phase 3
18 Hartmann's Versus Primary Anastomosis in Left-sided Colon Perforation Completed NCT01233713 Phase 2, Phase 3
19 Fluconazole Prophylaxis for the Prevention of Candidiasis in Infants Less Than 750 Grams Birthweight Completed NCT00734539 Phase 3
20 Vitamin D Supplementation for Extremely Preterm Infants Completed NCT01600430 Phase 2, Phase 3
21 Hartmann vs R/A in Peritonitis by Perforated Diverticulitis Completed NCT01239927 Phase 2, Phase 3
22 Antibiotic Prophylaxis in the Prevention of Surgical Site Infections After Selected Urgent Abdominal Surgical Procedures Completed NCT01524081 Phase 3
23 Effect of a Probiotic on Diverticular Symptoms Completed NCT02115867 Phase 3
24 Diagnosis of Acute Appendicitis: Low-dose Computed Tomography (CT) Versus Standard-dose CT Completed NCT00913380 Phase 3
25 A Comparison of Safety and Treatment in Subjects With Osteoarthritis Taking Low Dose Aspirin Completed NCT00175032 Phase 3
26 Intestinal Lavage for the Treatment of Severe C. Difficile Infections Recruiting NCT02466698 Phase 2, Phase 3
27 Open-label, Single Arm Trial of BI 695502 in Patients With Previously Untreated Metastatic Colorectal Cancer Recruiting NCT02776683 Phase 3
28 Adjuvant HIPEC in High Risk Colon Cancer Recruiting NCT02231086 Phase 3
29 Effects of Recto-colic Enemas of Butyrate on the Digestive Disorders of Very Low Birth Weight Preterms <1250 Grams Terminated NCT01536483 Phase 2, Phase 3
30 A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections Terminated NCT01110382 Phase 3
31 Resolution Endoclips Vs Epinephrine Injection and Heater Probe Terminated NCT00165009 Phase 3
32 Perforated Appendicitis With Delayed Presentation Unknown status NCT01068288 Phase 2
33 Prebiotics in the Prevention of Necrotizing Enterocolitis Unknown status NCT00437567 Phase 2
34 Pentoxifylline in the Treatment of NEC in Premature Neonates Unknown status NCT00271336 Phase 2
35 IPHC in Patients With Platinum-sensitive Recurrent Ovarian Cancer Completed NCT01588964 Phase 2
36 Paclitaxel and Carboplatin With Or Without Sorafenib In The First-Line Treatment Of Patients With Ovarian Cancer Completed NCT00390611 Phase 2
37 Vargatef in Addition to First Line Chemotherapy With Interval Debulking Surgery in Patients With Ovarian Cancer Completed NCT01583322 Phase 2
38 Vinorelbine and Bevacizumab in Treating Older Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Completed NCT00309998 Phase 2
39 Effects of Extensive Abdominal Lavage on Postoperative Inflammation Following Full Thickness Excision of Deep Endometriosis Completed NCT00930696 Phase 2
40 Temozolomide Plus Bevacizumab in Supratentorial Glioblastoma in 70 Years and Older Patients With an Impaired Functional Status Completed NCT02898012 Phase 2
41 Efficacy and Safety of Meloxicam vs. Naproxen Sodium in Patients With Acute Non Bacterial Pharyngitis or Pharyngo-tonsillitis Completed NCT02183038 Phase 2
42 Efficacy and Safety Study of Meloxicam Versus Mefenamic Acid in Patients With Dysmenorrhea Completed NCT02183025 Phase 2
43 Intensity-Modulated Radiation Therapy to the Pelvis With or Without Chemotherapy in Treating Patients With Endometrial Cancer or Cervical Cancer That Has Been Removed By Surgery Completed NCT00331760 Phase 2
44 Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus Recruiting NCT01958320 Phase 2
45 Paracetamol in Patent Ductus Arteriosus Recruiting NCT02422966 Phase 2
46 Dilute Povidone-iodine Irrigation vs No Irrigation for Children With Acute, Perforated Appendicitis Recruiting NCT02664220 Phase 2
47 Conservative Versus Operative ManageMent of Acute Uncomplicated Appendicitis Recruiting NCT02916134 Phase 2
48 First Line Treatment by FOLFIRINOX for Patients With a Rectum Cancer With Synchronous Non Resectable Metastasis Active, not recruiting NCT01674309 Phase 2
49 Trial Evaluating the Efficacy of Systemic Mesenchymal Stromal Cell (MSC) Injections for the Treatment of Severe and Chronic Radiotherapy-induced Abdomino-pelvic Complications (Pelvic Radiation Disease, PRD) Refractory to Standard Therapy Not yet recruiting NCT02814864 Phase 2
50 Clinical Trial Comparing ERAT vs Antibiotic Therapy vs Appendectomy for Treatment of Uncomplicated Acute Appendicitis Not yet recruiting NCT02789865 Phase 2

Search NIH Clinical Center for Intestinal Perforation

Cochrane evidence based reviews: intestinal perforation

Genetic Tests for Intestinal Perforation

Anatomical Context for Intestinal Perforation

MalaCards organs/tissues related to Intestinal Perforation:

39
Small Intestine, Bone, Lung, Colon, Testes, Liver, Breast

Publications for Intestinal Perforation

Articles related to Intestinal Perforation:

(show top 50) (show all 463)
id Title Authors Year
1
Blood Level of Inter-Alpha Inhibitor Proteins Distinguishes Necrotizing Enterocolitis From Spontaneous Intestinal Perforation. ( 27745748 )
2017
2
NOD2 Loss-of-Function Mutations and Risks of Necrotizing Enterocolitis or Focal Intestinal Perforation in Very Low-birth-weight Infants. ( 26752461 )
2016
3
Successful Kidney and Lung Transplantation From a Deceased Donor With Blunt Abdominal Trauma and Intestinal Perforation. ( 27500248 )
2016
4
A Fatal Complication: Intestinal Perforation Secondary to Migration of a Biliary Stent. ( 27141238 )
2016
5
Intestinal perforation due to paradoxical reaction during treatment for miliary tuberculosis. ( 28031831 )
2016
6
Intestinal perforation by an ingested foreign body. ( 27818542 )
2016
7
Henoch-SchAPnlein purpura from vasculitis to intestinal perforation: A case report and literature review. ( 27468201 )
2016
8
Surgery for the palliation of intestinal perforation from secondary metastases in advanced malignancies. ( 27075105 )
2016
9
Intestinal Perforation Following Ileoscopy Through a Prolapsed Stoma in an Pediatric Intestinal Transplant Recipient With an Unrecognized Parastomal Hernia. ( 27807575 )
2016
10
Spontaneous Intestinal Perforation in a Very Low Birth Weight Infant: Successful Management by Peritoneal Needle Suction. ( 27433457 )
2016
11
Intestinal perforation during chemotherapeutic treatment of intra-abdominal desmoid tumor in patients with Gardner's syndrome: report of two cases. ( 27377916 )
2016
12
Eosinophilic enteritis due to cow's milk allergy: Possible cause of anastomosis failure following repair of focal intestinal perforation. ( 26841092 )
2016
13
Intestinal perforation management using T-tube drainage. ( 27177890 )
2016
14
Rheumatoid arthritis: Tocilizumab and the risk of intestinal perforation. ( 27464481 )
2016
15
Intestinal Perforation in Renal Transplant Recipients: A Single Center Experience of 2123 Recipients. ( 27228089 )
2016
16
Spontaneous Intestinal Perforation: The Long-Term Outcome. ( 27846663 )
2016
17
Prophylactic efficacy of enteral miconazole administration for neonatal intestinal perforation and its potential mechanism. ( 27473010 )
2016
18
Intestinal Perforation in Obstructed Umbilical Hernia due to Wedged Plum Seed. ( 27398326 )
2016
19
Long term outcome of preterm infants with isolated intestinal perforation: A comparison between primary anastomosis and ileostomy. ( 27059790 )
2016
20
BehAset's disease with intestinal perforation: A case report. ( 27141811 )
2016
21
Surgical Necrotizing Enterocolitis versus Spontaneous Intestinal Perforation in White Matter Injury on Brain Magnetic Resonance Imaging. ( 27105356 )
2016
22
Closure of an intestinal perforation with an autologous fat plug in a man with Crohn's disease. ( 27489994 )
2016
23
Severe Hypokalaemia, Hypertension, and Intestinal Perforation in Ectopic Adrenocorticotropic Hormone Syndrome. ( 26894113 )
2016
24
An Unusual Cause of Intestinal Perforation. ( 27926750 )
2016
25
Congenital Mesenteric Defect: A Rare Cause of Intestinal Perforation. ( 27595576 )
2016
26
Effect of prophylactic indomethacin administration and early feeding on spontaneous intestinal perforation in extremely low-birth-weight infants. ( 27763630 )
2016
27
Intestinal Perforation Due to Foreign Body Ingestion in a Schizophrenic Patient. ( 27803892 )
2016
28
The antecedents and correlates of necrotizing enterocolitis and spontaneous intestinal perforation among infants born before the 28th week of gestation. ( 27197933 )
2016
29
Definitive peritoneal drainage in the extremely low birth weight infant with spontaneous intestinal perforation: predictors and hospital outcomes. ( 25856761 )
2015
30
Letter to the editor: gallstone ileus, volvulus, and intestinal perforation in a patient with cholecystotomy and choledochoduodenostomy: a case report. ( 26123700 )
2015
31
Use of recombinant human soluble thrombomodulin in patients with sepsis-induced disseminated intravascular coagulation after intestinal perforation. ( 25767801 )
2015
32
Influence of surgical intervention on neurodevelopmental outcome in infants with focal intestinal perforation. ( 25676146 )
2015
33
Intestinal perforation in very preterm neonates: risk factors and outcomes. ( 25927271 )
2015
34
The impact of early surgical intervention in free intestinal perforation: a time-to-intervention pilot study. ( 26550026 )
2015
35
A comparative study of small intestinal perforation secondary to foreign body and other non-traumatic causes. ( 25904271 )
2015
36
Intestinal perforation in premature neonates: The need for subsequent laparotomy after placement of peritoneal drains. ( 26515522 )
2015
37
Systemic lupus erythematosus with intestinal perforation: A case report. ( 26622471 )
2015
38
Spontaneous intestinal perforation in neonates. ( 26034708 )
2015
39
Spontaneous Intestinal Perforation and Infantile Hypertrophic Pyloric Stenosis in a Preterm Neonate: A Linked Etiopathogenesis? ( 26055488 )
2015
40
Injuries of myocardial cells and changes of myocardial enzymes after firearm wound-induced intestinal perforation in porcine abdomen. ( 25932162 )
2015
41
Spontaneous Intestinal Perforation and Necrotizing Enterocolitis: A 16-Year Retrospective Study from a Single Center. ( 25643249 )
2015
42
Acute fulminant necrotizing amoebic colitis leading to intestinal perforation and peritonitis. ( 25628999 )
2015
43
Intestinal perforation as the initial presentation of polyarteritis nodosa in an older adult. ( 25583391 )
2015
44
Comparative MiRNA Expressional Profiles and Molecular Networks in Human Small Bowel Tissues of Necrotizing Enterocolitis and Spontaneous Intestinal Perforation. ( 26274503 )
2015
45
Unusual cause of intestinal perforation in granulomatosis with polyangiitis (Wegener's). ( 26578158 )
2015
46
What Is Your Diagnosis? Mycosis leading to cranial mesenteric pseudoaneurysm and secondary intestinal perforation with septic peritonitis. ( 26295548 )
2015
47
Typhoid glomerulonephritis and intestinal perforation in a Nigerian child. ( 25244281 )
2014
48
Neurodevelopmental outcomes of extremely low birth weight infants with spontaneous intestinal perforation or surgical necrotizing enterocolitis. ( 24135709 )
2014
49
Mortality associated with laparotomy-confirmed neonatal spontaneous intestinal perforation: a prospective 5-year multicenter analysis. ( 25092079 )
2014
50
Case fatality rate and length of hospital stay among patients with typhoid intestinal perforation in developing countries: a systematic literature review. ( 24743649 )
2014

Variations for Intestinal Perforation

Expression for Intestinal Perforation

Search GEO for disease gene expression data for Intestinal Perforation.

Pathways for Intestinal Perforation

GO Terms for Intestinal Perforation

Cellular components related to Intestinal Perforation according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 mitochondrion GO:0005739 9.02 ACAT1 ALDH18A1 NFKB1 NOS1 PTS
2 specific granule lumen GO:0035580 8.96 DEFA4 NFKB1

Biological processes related to Intestinal Perforation according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 positive regulation of transcription from RNA polymerase II promoter GO:0045944 9.78 NFKB1 NKX2-1 NOD2 NOS1
2 defense response to Gram-positive bacterium GO:0050830 9.46 DEFA1 DEFA4
3 response to hormone GO:0009725 9.43 ACAT1 NKX2-1
4 defense response to bacterium GO:0042742 9.43 DEFA1 DEFA4 NOD2
5 antimicrobial humoral response GO:0019730 9.4 DEFA1 DEFA4
6 antibacterial humoral response GO:0019731 9.37 DEFA1 DEFA4
7 killing of cells of other organism GO:0031640 9.32 DEFA1 DEFA4
8 innate immune response GO:0045087 9.26 DEFA1 DEFA4 NFKB1 NOD2
9 defense response to fungus GO:0050832 9.16 DEFA1 DEFA4
10 defense response GO:0006952 8.8 DEFA1 DEFA4 NOD2

Molecular functions related to Intestinal Perforation according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 enzyme binding GO:0019899 8.8 ACAT1 NKX2-1 NOD2

Sources for Intestinal Perforation

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....